Literature DB >> 2624920

Homogeneous penetration but heterogeneous binding of antibodies to carcinoembryonic antigen in human colon carcinoma HT-29 spheroids.

J Carlsson1, E Daniel-Szolgay, G Frykholm, B Glimelius, A Hedin, B Larsson.   

Abstract

The monoclonal antibodies 38S1, directed against the carcinoembryonic antigen (CEA), were tested for penetration and binding in human colon carcinoma HT-29 spheroids. Penetration was studied with a method which has not previously been used in immunological investigations. The method, which allows unbound substances to be visualized, is based on freeze drying, vapour fixation, dry sectioning and dry autoradiography. The antibodies penetrated easily and all parts of the HT-29 spheroids seemed to be reached within 15 min. The penetration was even faster than in control glioma U-118MG spheroids that did not express CEA. Binding of the 38S1 antibodies was demonstrated after processing with conventional histology and autoradiography. The binding in the HT-29 spheroids was, after a 1-h incubation period, extremely heterogeneous and occurred mainly in the peripheral parts. More cells were binding the antibodies after 8-h and 32-h incubations and these cells were arranged in peripheral clusters. No binding at all was seen in the CEA-negative glioma spheroids. The distribution of CEA antigens in monolayers and in frozen sections of spheroids of HT-29 cells was analysed with immunohistochemical staining using polyclonal CEA antibodies. The CEA antigens were heterogeneously distributed in both spheroids and monolayers and were as heterogenous as the binding of the monoclonal antibodies in the living spheroids. Thus, the heterogeneous binding in the living spheroids was not due to penetration barriers, but instead to the heterogeneity in the CEA antigen expression.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2624920     DOI: 10.1007/bf01744893

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  24 in total

1.  Uptake kinetics of monoclonal antibodies by human malignant melanoma multicell spheroids.

Authors:  C S Kwok; S E Cole; S K Liao
Journal:  Cancer Res       Date:  1988-04-01       Impact factor: 12.701

2.  Role of necrosis in regulating the growth saturation of multicellular spheroids.

Authors:  J P Freyer
Journal:  Cancer Res       Date:  1988-05-01       Impact factor: 12.701

3.  Glycosaminoglycan synthesis by mammary tumor spheroids.

Authors:  J C Angello; H L Hosick
Journal:  Biochem Biophys Res Commun       Date:  1982-08       Impact factor: 3.575

4.  Human colonic adenocarcinoma cells. I. Establishment and description of a new line.

Authors:  B H Tom; L P Rutzky; M M Jakstys; R Oyasu; C I Kaye; B D Kahan
Journal:  In Vitro       Date:  1976-03

5.  Use of limitations of radiolabeled anti-CEA antibodies and their fragments for photoscanning detection of human colorectal carcinomas.

Authors:  J P Mach; M Forni; J Ritschard; F Buchegger; S Carrel; S Widgren; A Donath; P Alberto
Journal:  Oncodev Biol Med       Date:  1980-08

6.  Tumor localization of CEA-containing human tumors in nude mice by means of monoclonal anti-CEA antibodies.

Authors:  A Hedin; B Wahren; S Hammarström
Journal:  Int J Cancer       Date:  1982-11-15       Impact factor: 7.396

7.  Penetration and binding of radiolabeled anti-carcinoembryonic antigen monoclonal antibodies and their antigen binding fragments in human colon multicellular tumor spheroids.

Authors:  R Sutherland; F Buchegger; M Schreyer; A Vacca; J P Mach
Journal:  Cancer Res       Date:  1987-03-15       Impact factor: 12.701

8.  Extracellular matrices in multicellular spheroids of human glioma origin: increased incorporation of proteoglycans and fibronectin as compared to monolayer cultures.

Authors:  B Glimelius; B Norling; T Nederman; J Carlsson
Journal:  APMIS       Date:  1988-05       Impact factor: 3.205

9.  DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES.

Authors:  P GOLD; S O FREEDMAN
Journal:  J Exp Med       Date:  1965-03-01       Impact factor: 14.307

10.  A tumour spheroid model for antibody-targeted therapy of micrometastases.

Authors:  K A Walker; T Murray; T E Hilditch; T E Wheldon; A Gregor; I M Hann
Journal:  Br J Cancer       Date:  1988-07       Impact factor: 7.640

View more
  6 in total

1.  Relations between the penetration, binding and average concentration of cytostatic drugs in human tumour spheroids.

Authors:  M Erlanson; E Daniel-Szolgay; J Carlsson
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

2.  Effects of 131I-EGF on cultured human glioma cells.

Authors:  J Capala; M Pråhl; S Scott-Robson; J Pontén; B Westermark; J Carlsson
Journal:  J Neurooncol       Date:  1990-12       Impact factor: 4.130

3.  Effects of EGF-dextran-tyrosine-131I conjugates on the clonogenic survival of cultured glioma cells.

Authors:  A Andersson; J Capala; J Carlsson
Journal:  J Neurooncol       Date:  1992-11       Impact factor: 4.130

4.  Heterogeneity in antigenic expression and radiosensitivity in human colon carcinoma cell lines.

Authors:  G Frykholm; B Glimelius; S Richter; J Carlsson
Journal:  In Vitro Cell Dev Biol       Date:  1991-12

5.  DC electrical field-induced c-fos expression and growth stimulation in multicellular prostate cancer spheroids.

Authors:  H Sauer; J Hescheler; D Reis; H Diedershagen; W Niedermeier; M Wartenberg
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

6.  Monoclonal antibody Po66 uptake by human lung tumours implanted in nude mice: effect of co-administration with doxorubicin.

Authors:  B Desrues; H Léna; F Brichory; M P Ramée; L Toujas; P Delaval; L Dazord
Journal:  Br J Cancer       Date:  1995-11       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.